We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Reliance Study

Roflumilast or Azithromycin to Prevent COPD Exacerbations

lung illustration
Age: 40 years and older
Sex at Birth: All
Type: Interventional Study
Condition: Chronic Obstructive Pulmonary Disease
Healthy Participants: Yes
Location: UH Cleveland Medical Center

Learn More About This Research Study

For more information, please contact Mario Becerra, RN at 216-844-1734 or complete the online form below.

Study Purpose

The purpose of this study is to compare two drugs, Azithromycin or Roflumilast, that doctors are planning to prescribe for their patients with Chronic Obstructive Pulmonary Disease.

Who Can Participate

Participants 40 years or older diagnosed with Chronic Obstructive Pulmonary Disease whose physician plans to presecribe Azithromycin or Roflumilast may be eligible for this study.

Request More Information

To learn more about this study, please fill out the form below to request more information.

I'm not a robot